Willemien J Kruik-Kollöffel (W J Kruik-Kollöffel)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Angiotensin Converting Enzyme

Prognostic Factors

Recombinant Human

Top Venues

International journal of clinical pharmacy

Clinical drug investigation

Heart failure reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Willemien J Kruik-Kollöffel, G A W Moltman, M D Wu, A Braaksma, F Karapinar, R J Boucherie
Optimisation of medication reconciliation using queueing theory: a computer experiment. International journal of clinical pharmacy 46 (4) (2024)
Willemien J Kruik-Kollöffel, G A W Moltman, M D Wu, A Braaksma, F Karapinar, R J Boucherie
Optimisation of medication reconciliation using queueing theory: a computer experiment. International journal of clinical pharmacy (2024)
Willemien J Kruik-Kollöffel, G A W Moltman, M D Wu, A Braaksma, F Karapinar, R J Boucherie
Optimisation of medication reconciliation using queueing theory: a computer experiment. International journal of clinical pharmacy 46 (4) (2024)
Willemien J Kruik-Kollöffel, Enriqueta Vallejo-Yagüe, Kris L L Movig, Gerard C M Linssen, Edith M Heintjes, Job van der Palen
Non-cardiovascular medication and readmission for heart failure: an observational cohort study. International journal of clinical pharmacy 44 (3) (2022)
Willemien J Kruik-Kollöffel, Gerard C M Linssen, H Joost Kruik, Kris L L Movig, Edith M Heintjes, Job van der Palen
Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015. Heart failure reviews 24 (4) (2020)
Willemien J Kruik-Kollöffel, Job van der Palen, Carine J M Doggen, Marissa C Van Maaren, H Joost Kruik, Edith M Heintjes, Kris L L Movig, Gerard C M Linssen
Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases. PloS one 15 (12) (2020)
Willemien J Kruik-Kollöffel, Job van der Palen, Myrthe P P van Herk-Sukel, H Joost Kruik, Kris L L Movig
Decrease in Switches to 'Unsafe' Proton Pump Inhibitors After Communications About Interactions with Clopidogrel. Clinical drug investigation 37 (8) (2018)